Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088523931> ?p ?o ?g. }
- W2088523931 endingPage "1088" @default.
- W2088523931 startingPage "1085" @default.
- W2088523931 abstract "Despite advances in the development of anti-angiogenic agents for cancer treatment, the increase in the survival duration of cancer patients is still rather modest. One major obstacle in anti-angiogenic therapy is the emergence of drug resistance. Understanding the molecular mechanisms that enable a tumour to evade anti-angiogenic treatment is valuable to improve therapeutic efficacy. Targeting blood supply usually causes hypoxic responses of tumours that trigger a series of adaptive changes leading to a resistant phenotype. Periostin, a secreted ECM (extracellular matrix) protein, is mainly produced by CAFs (cancer-associated fibroblasts) on hypoxic stress. As CAFs have been casually linked to tumour resistance to angiogenesis blockade and periostin can influence many aspects of tumour biology, we hypothesized that periostin might be a crucial mediator involved anti-angiogenic resistance in cancer treatment. This hypothesis is indirectly supported by the following facts: (a) high levels of periostin promote tumour angiogenesis; (b) periostin improves cancer cell survival under hypoxic conditions; and (c) genetic modulation of periostin induces EMT (epithelial-mesenchymal transition) and enhances cancer cell invasion and metastasis, which represents an escape mechanism from anticancer treatment. Testing and confirmation of this hypothesis will give more insight into the resistance mechanisms and provide the rationale for improvement of therapeutic outcome of anti-angiogenic therapy." @default.
- W2088523931 created "2016-06-24" @default.
- W2088523931 creator A5032159354 @default.
- W2088523931 creator A5033497327 @default.
- W2088523931 creator A5046597133 @default.
- W2088523931 creator A5061065826 @default.
- W2088523931 date "2011-09-27" @default.
- W2088523931 modified "2023-09-24" @default.
- W2088523931 title "Periostin: a putative mediator involved in tumour resistance to anti-angiogenic therapy?" @default.
- W2088523931 cites W1504049064 @default.
- W2088523931 cites W1910862521 @default.
- W2088523931 cites W1967600348 @default.
- W2088523931 cites W1973554995 @default.
- W2088523931 cites W1973671404 @default.
- W2088523931 cites W2005818888 @default.
- W2088523931 cites W2018081011 @default.
- W2088523931 cites W2020065664 @default.
- W2088523931 cites W2028904725 @default.
- W2088523931 cites W2033791403 @default.
- W2088523931 cites W2035371717 @default.
- W2088523931 cites W2036678386 @default.
- W2088523931 cites W2041125186 @default.
- W2088523931 cites W2062809449 @default.
- W2088523931 cites W2076287672 @default.
- W2088523931 cites W2084892018 @default.
- W2088523931 cites W2092657747 @default.
- W2088523931 cites W2094488761 @default.
- W2088523931 cites W2095486010 @default.
- W2088523931 cites W2103928688 @default.
- W2088523931 cites W2105849179 @default.
- W2088523931 cites W2118501663 @default.
- W2088523931 cites W2120179477 @default.
- W2088523931 cites W2123522555 @default.
- W2088523931 cites W2140088548 @default.
- W2088523931 cites W2142836510 @default.
- W2088523931 cites W2150050975 @default.
- W2088523931 cites W2154613259 @default.
- W2088523931 cites W2158687576 @default.
- W2088523931 cites W2158743409 @default.
- W2088523931 cites W2168649860 @default.
- W2088523931 cites W2170556339 @default.
- W2088523931 cites W4243218074 @default.
- W2088523931 cites W4252851641 @default.
- W2088523931 doi "https://doi.org/10.1042/cbi20110171" @default.
- W2088523931 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21999314" @default.
- W2088523931 hasPublicationYear "2011" @default.
- W2088523931 type Work @default.
- W2088523931 sameAs 2088523931 @default.
- W2088523931 citedByCount "9" @default.
- W2088523931 countsByYear W20885239312012 @default.
- W2088523931 countsByYear W20885239312013 @default.
- W2088523931 countsByYear W20885239312017 @default.
- W2088523931 countsByYear W20885239312019 @default.
- W2088523931 countsByYear W20885239312020 @default.
- W2088523931 countsByYear W20885239312022 @default.
- W2088523931 crossrefType "journal-article" @default.
- W2088523931 hasAuthorship W2088523931A5032159354 @default.
- W2088523931 hasAuthorship W2088523931A5033497327 @default.
- W2088523931 hasAuthorship W2088523931A5046597133 @default.
- W2088523931 hasAuthorship W2088523931A5061065826 @default.
- W2088523931 hasConcept C121608353 @default.
- W2088523931 hasConcept C126322002 @default.
- W2088523931 hasConcept C189165786 @default.
- W2088523931 hasConcept C203014093 @default.
- W2088523931 hasConcept C2107291 @default.
- W2088523931 hasConcept C2777699602 @default.
- W2088523931 hasConcept C2779013556 @default.
- W2088523931 hasConcept C2780394083 @default.
- W2088523931 hasConcept C502942594 @default.
- W2088523931 hasConcept C71924100 @default.
- W2088523931 hasConcept C86803240 @default.
- W2088523931 hasConcept C95444343 @default.
- W2088523931 hasConcept C96232424 @default.
- W2088523931 hasConceptScore W2088523931C121608353 @default.
- W2088523931 hasConceptScore W2088523931C126322002 @default.
- W2088523931 hasConceptScore W2088523931C189165786 @default.
- W2088523931 hasConceptScore W2088523931C203014093 @default.
- W2088523931 hasConceptScore W2088523931C2107291 @default.
- W2088523931 hasConceptScore W2088523931C2777699602 @default.
- W2088523931 hasConceptScore W2088523931C2779013556 @default.
- W2088523931 hasConceptScore W2088523931C2780394083 @default.
- W2088523931 hasConceptScore W2088523931C502942594 @default.
- W2088523931 hasConceptScore W2088523931C71924100 @default.
- W2088523931 hasConceptScore W2088523931C86803240 @default.
- W2088523931 hasConceptScore W2088523931C95444343 @default.
- W2088523931 hasConceptScore W2088523931C96232424 @default.
- W2088523931 hasIssue "11" @default.
- W2088523931 hasLocation W20885239311 @default.
- W2088523931 hasLocation W20885239312 @default.
- W2088523931 hasOpenAccess W2088523931 @default.
- W2088523931 hasPrimaryLocation W20885239311 @default.
- W2088523931 hasRelatedWork W1578863196 @default.
- W2088523931 hasRelatedWork W2049739326 @default.
- W2088523931 hasRelatedWork W2058903925 @default.
- W2088523931 hasRelatedWork W2088523931 @default.
- W2088523931 hasRelatedWork W2154613259 @default.
- W2088523931 hasRelatedWork W2154708791 @default.
- W2088523931 hasRelatedWork W2392059389 @default.